MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 6, 2007; DOI: 10.1124/mol.106.031492


0026-895X/07/7106-1563-1571$20.00
Mol Pharmacol 71:1563-1571, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.031492v1
71/6/1563    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salminen, O.
Right arrow Articles by Grady, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salminen, O.
Right arrow Articles by Grady, S. R.

Pharmacology of {alpha}-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice

Outi Salminen1, Jennifer A. Drapeau, J. Michael McIntosh, Allan C. Collins, Michael J. Marks, and Sharon R. Grady

Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado (O.S., J.A.D., E.L., M.C., A.C.C., M.J.M., S.R.G.); and Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah (J.M.M.)

Subtypes of nicotinic acetylcholine receptors (nAChR) containing {alpha}6 subunits comprise 25 to 30% of the presynaptic nAChRs expressed in striatal dopaminergic terminals in rodents and 70% in monkeys. This class of receptors, potentially important in nicotine addiction, binds {alpha}-conotoxin MII ({alpha}-CtxMII) with high affinity and is heterogeneous, consisting of several subtypes in mice, possibly an important consideration for the design of compounds that selectively activate or antagonize the {alpha}6 subclass of nAChRs. Selected-null mutant mice were bred to generate isolated subtypes of {alpha}6beta2* nAChRs expressed in vivo for assessing pharmacology of {alpha}6beta2* nAChRs. Binding to striatal membranes and function in synaptosomes from ({alpha}4–/–)(beta3+/+) and ({alpha}4–/–)(beta3–/–) mice were measured and compared with wild-type ({alpha}4+/+)(beta3+/+) mice. Gene deletions ({alpha}4 and beta3) decreased binding of 125I-{alpha}-CtxMII without affecting affinity for {alpha}-CtxMII or inhibition of {alpha}-CtxMII binding by epibatidine or nicotine. Deletion of the {alpha}4 subunit substantially increased EC50 values for both nicotine- and cytisine-stimulated {alpha}-CtxMII-sensitive dopamine release from striatal synaptosomes. A further increase in EC50 values was seen upon the additional deletion of the beta3 subunit. The data indicate that one {alpha}-CtxMII-sensitive nAChR subtype, prevalent on wild-type dopaminergic terminals, has the lowest EC50 for a nicotine-mediated function so far measured in mice. In conclusion, the gene deletion strategy enabled isolation of {alpha}6* subtypes, and these nAChR subtypes exhibited differential activation by nicotine and cytisine.


Received October 4, 2006; accepted March 6, 2007

Address correspondence to: Sharon R. Grady, Institute for Behavioral Genetics, University of Colorado, 447UCB, Boulder, CO 80309. E-mail: sharon.grady{at}colorado.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. P. Dwoskin, T. E. Wooters, S. P. Sumithran, K. B. Siripurapu, B. M. Joyce, P. R. Lockman, V. K. Manda, J. T. Ayers, Z. Zhang, A. G. Deaciuc, et al.
N,N'-Alkane-diyl-bis-3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-Evoked Dopamine Release and Hyperactivity
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 563 - 576.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Onksen, and J. Lindstrom
Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors
Mol. Pharmacol., July 1, 2008; 74(1): 132 - 143.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. M. Drenan, R. Nashmi, P. Imoukhuede, H. Just, S. McKinney, and H. A. Lester
Subcellular Trafficking, Pentameric Assembly, and Subunit Stoichiometry of Neuronal Nicotinic Acetylcholine Receptors Containing Fluorescently Labeled {alpha}6 and 3 Subunits
Mol. Pharmacol., January 1, 2008; 73(1): 27 - 41.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics